Top Markets
Coin of the day
Hunan Er-Kang Pharmaceutical Co., Ltd Hunan Er-Kang Pharmaceutical Co., Ltd

Hunan Er-Kang Pharmaceutical Co., Ltd

300267
주식 순위 #9472
Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that... Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.
주가
$0.48835979
마지막 동기화: 2026-08-28
시가총액
$1.01B
변동 (1일)
-1.46%
변동 (1년)
-9.78%
국가
CN
거래 Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

카테고리

Hunan Er-Kang Pharmaceutical Co., Ltd (300267)의 주식 분할 이력
Hunan Er-Kang Pharmaceutical Co., Ltd 주식 (심볼: 300267)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 29, 2026에 발생했습니다.
Aug 29, 2026 이전에 매수한 300267 주식 1주는 현재 0주의 300267 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할